How is an emergency correction dose of regular insulin calculated based on the current capillary blood glucose level?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Emergency Regular Insulin Dosing Based on Capillary Blood Glucose

For emergency correction of hyperglycemia in hospitalized non-critically ill patients, use a standardized supplemental insulin scale based on the current CBG level and the patient's insulin sensitivity, administering regular insulin every 6 hours or rapid-acting insulin every 4-6 hours. 1

Standardized Correction Dose Scale

The Endocrine Society provides a validated correction insulin scale that should be applied based on three patient categories 1:

Insulin-Sensitive Column (Start Here For):

  • Patients who are NPO (not eating)
  • Elderly patients (≥70 years)
  • Patients with impaired renal function (GFR <60 mL/min)

Usual Column (Start Here For):

  • Most patients able to eat
  • Standard insulin requirements

Insulin-Resistant Column (Start Here For):

  • Patients receiving corticosteroids
  • Patients previously treated with >80 units/day of insulin

Correction Dose Table

CBG (mg/dL) Insulin-Sensitive Usual Insulin-Resistant
141-180 2 units 4 units 6 units
181-220 4 units 6 units 8 units
221-260 6 units 8 units 10 units
261-300 8 units 10 units 12 units
301-350 10 units 12 units 14 units
351-400 12 units 14 units 16 units
≥400 14 units 16 units 18 units

1

Administration Timing

Regular insulin: Administer every 6 hours (at 6-12-6-12 schedule) 1

Rapid-acting insulin analog: Administer every 4-6 hours 1

For eating patients: Give correction dose before each meal and at bedtime, using the "Usual" column. Give half the supplemental insulin dose at bedtime. 1

Critical Implementation Points

Common Pitfalls to Avoid:

  1. Never use sliding-scale insulin (SSI) as monotherapy - This outdated approach increases the risk of hyperglycemia 3-fold and results in undesirable glycemic control 1. Correction insulin should be part of a scheduled basal-bolus regimen, not standalone therapy.

  2. Adjust for renal function - Patients with kidney failure have decreased insulin clearance and require lower starting doses in the insulin-sensitive column 2.

  3. Account for insulin action time - Regular insulin has 4-6 hours of action. Do not "stack" doses by giving correction insulin more frequently than every 6 hours with regular insulin 3.

  4. Bedtime dosing reduction - Always give only half the correction dose at bedtime to prevent nocturnal hypoglycemia 1.

Alternative Calculation Method (Insulin Sensitivity Factor)

For patients on established insulin regimens, you can calculate correction doses using the insulin sensitivity factor (ISF):

For regular insulin: ISF = 1500 ÷ Total Daily Dose (TDD) of insulin 3

For rapid-acting insulin: ISF = 1800 ÷ TDD of insulin 3

This tells you how many mg/dL one unit of insulin will lower the blood glucose. For example, if a patient uses 50 units/day total: 1800 ÷ 50 = 36 mg/dL reduction per unit.

Correction dose = (Current CBG - Target CBG) ÷ ISF

However, this method requires knowledge of the patient's home insulin regimen and is more complex than using the standardized scale above.

When to Escalate

If CBG remains persistently >240 mg/dL despite correction doses, the patient requires initiation or adjustment of scheduled basal-bolus insulin therapy, not just increased correction doses 1. In one study, 14% of patients on SSI alone required rescue with basal-bolus insulin due to persistent hyperglycemia 1.

For critically ill patients or those with CBG consistently >300 mg/dL, consider continuous intravenous insulin infusion rather than subcutaneous correction doses 4, 2.

References

Guideline

american association of clinical endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan-2022 update.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2022

Guideline

management of diabetes and hyperglycaemia in the hospital.

The Lancet Diabetes and Endocrinology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.